Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Macroautophagy/autophagy is a lysosomal degradation system which plays a protective role against kidney injury. RUBCN/Rubicon (RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein) inhibits the fusion of autophagosomes and lysosomes. However, its physiological role in kidney proximal tubular epithelial cells (PTECs) remains uncertain. In the current study, we analyzed the phenotype of newly generated PTEC-specific rubcn-deficient (KO) mice. Additionally, we investigated the role of RUBCN in lipid metabolism using isolated rubcn-deficient PTECs. Although KO mice exhibited sustained high autophagic flux in PTECs, they were not protected from acute ischemic kidney injury. Unexpectedly, KO mice exhibited hallmark features of metabolic syndrome accompanied by expanded lysosomes containing multi-layered phospholipids in PTECs. RUBCN deficiency in cultured PTECs promoted the mobilization of phospholipids from cellular membranes to lysosomes via enhanced autophagy. Treatment of KO PTECs with oleic acid accelerated fatty acids transfer to mitochondria. Furthermore, KO PTECs promoted massive triglyceride accumulation in hepatocytes (BNL-CL2 cells) co-cultured in transwell, suggesting accelerated fatty acids efflux from the PTECs contributes to the metabolic syndrome in KO mice. This study shows that sustained high autophagic flux by RUBCN deficiency in PTECs leads to metabolic syndrome concomitantly with an accelerated mobilization of phospholipids from cellular membranes to lysosomes.Abbreviations: ABC: ATP binding cassette; ACADM: acyl-CoA dehydrogenase medium chain; ACTB: actin, beta; ATG: autophagy related; AUC: area under the curve; Baf: bafilomycin A1; BAT: brown adipose tissue; BODIPY: boron-dipyrromethene; BSA: bovine serum albumin; BW: body weight; CAT: chloramphenicol acetyltransferase; CM: complete medium; CPT1A: carnitine palmitoyltransferase 1a, liver; CQ: chloroquine; CTRL: control; EGFP: enhanced green fluorescent protein; CTSD: cathepsin D; EAT: epididymal adipose tissue; EGFR: epidermal growth factor receptor; EIF4EBP1: eukaryotic translation initiation factor 4E binding protein 1; FA: fatty acid; FBS: fetal bovine serum; GTT: glucose tolerance test; HE: hematoxylin and eosin; HFD: high-fat diet; I/R: ischemia-reperfusion; ITT: insulin tolerance test; KAP: kidney androgen regulated protein; KO: knockout; LAMP1: lysosomal associated membrane protein 1; LD: lipid droplet; LRP2: low density lipoprotein receptor related protein 2; MAP1LC3B: microtubule associated protein 1 light chain 3 beta; MAT: mesenteric adipose tissue; MS: mass spectrometry; MTOR: mechanistic target of rapamycin kinase; MTORC1: MTOR complex 1; NDRG1: N-myc downstream regulated 1; NDUFB5: NADH:ubiquinone oxidoreductase subunit B5; NEFA: non-esterified fatty acid; OA: oleic acid; OCT: optimal cutting temperature; ORO: Oil Red O; PAS: Periodic-acid Schiff; PFA: paraformaldehyde; PIK3C3: phosphatidylinositol 3-kinase catalytic subunit type 3; PPARA: peroxisome proliferator activated receptor alpha; PPARGC1A: PPARG coactivator 1 alpha; PTEC: proximal tubular epithelial cell; RAB7A: RAB7A, member RAS oncogene family; RPS6: ribosomal protein S6; RPS6KB1: ribosomal protein S6 kinase B1; RT: reverse transcription; RUBCN: rubicon autophagy regulator; SAT: subcutaneous adipose tissue; SFC: supercritical fluid chromatography; SQSTM1: sequestosome 1; SREBF1: sterol regulatory element binding transcription factor 1; SV-40: simian virus-40; TFEB: transcription factor EB; TG: triglyceride; TS: tissue specific; TUNEL: terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling; UN: urea nitrogen; UQCRB: ubiquinol-cytochrome c reductase binding protein; UVRAG: UV radiation resistance associated; VPS: vacuolar protein sorting; WAT: white adipose tissue.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By contrast, uncontrolled activation of autophagy as mediated by rubcn deletion fails to elicit renoprotective effects against IRI, possibly indicating autophagy‐independent function of the protein or because of autosis induction (Matsuda et al, 2020).”
From Autophagy in major human diseases (2021) · cites this paper as Matsuda et al, 2020
In the citing paper
“This result seems to corroborate the observations that the expression of the autophagy suppressor protein RUBCN increases over time, alongside exacerbated markers of defective lysosomal function (Matsuda et al, 2020).”
From Autophagy in major human diseases (2021) · cites this paper as Matsuda et al, 2020
In the citing paper
“| Acute kidney injury | Proximal TEC‐specific deletion of Rubcn | Increased sensitivity to ischemic injury, linked to increased fat efflux from cells to circulation, after autophagy activation | Matsuda et al (2020) |”
From Autophagy in major human diseases (2021) · cites this paper as Matsuda et al (2020)
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189 · cited 1×
“Total lipids in liver samples or cultured PTECs were extracted as described previously [36].”
MethodRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 1×
“MTORC1 directly phosphorylates the translational regulators eukaryotic translation initiation factor RPS6 (ribosomal protein S6), RPS6KB1/S6K1 (ribosomal protein S6 kinase B1), and EIF4EBP1/4E-BP1 (eukaryotic translation initiation factor 4E binding protein 1), all of which promote protein synthesis [20].”
BackgroundAutophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452 · cited 1×
“Macroautophagy/autophagy is one of the major degradation pathways in the cell along with the ubiquitin-proteasome system [1,2].”
BackgroundGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347 · cited 1×
“BECN1/Beclin 1, a mammalian homolog of the yeast autophagy protein Vps30/Atg6 (vacuolar protein sorting 30), has been shown to not only serve as a tumor suppressor but also regulate autophagy [8].”
BackgroundAutophagy in Human Health and Disease
Choi, A. M. K., Ryter, S. W., & Levine, B. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1205406 · Cited by 2,583 · cited 1×
“Macroautophagy/autophagy is one of the major degradation pathways in the cell along with the ubiquitin-proteasome system [1,2].”
BackgroundMizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., & Ohsumi, Y. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0704 · Cited by 2,105 · cited 2×
“To evaluate the autophagic flux precisely in vivo, we crossed Rubcn (Rubcn-CTRL [control]) or rubcn-TSKO mice with GFPMAP1LC3B (microtubule-associated protein 1 light chain 3 beta) transgenic mice, in which GFP-positive puncta reflect autophagosomes [17].”
MethodSelf-citationRoczniak-Ferguson, A., Petit, C. S., Froehlich, F., Qian, S., Ky, J., Angarola, B., Walther, T. C., & Ferguson, S. M. (2012) · Science Signaling · doi:10.1126/scisignal.2002790 · Cited by 1,366 · cited 1×
“TFEB (transcription factor EB), a master regulator of lysosomal biogenesis and autophagy, is phosphorylated and regulated in anMTORC1-dependent manner [21,22].”
Background
Research works printed but not linked: 1
- Uchida S, 1988, Am J Physiol, 255, F977
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationCurrent state and future perspectives of supercritical fluid chromatography
Le, S.-H., & Bamba, T. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116550 · Cited by 108
Self-citationLipid Droplet–Mitochondria Contacts in Health and Disease
Fan, H., & Tan, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136878 · Cited by 107
“These include the complexity of LD–mitochondria interactions, the need for tissue-specific targeting, and potential off-target effects [109,110].”
BackgroundClaude‐Taupin, A., Isnard, P., Bagattin, A., Kuperwasser, N., Roccio, F., Ruscica, B., Goudin, N., Garfa‐Traoré, M., Regnier, A., Turinsky, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43775-1 · Cited by 63
“…are in agreement with a recent study, which showed that Rubicon-de fi cient kidney proximal tubular cells exhibit high autophagy fl ux and accelerated LDs degradation 66 , suggesting the importance of balancing the activity of YAP/TAZ and thus autophagy, to maintain kidney tubular cells homeostasis.”
Yang, H., Sun, J., Sun, A., Yu, W., Xie, W., Xie, P., Zhang, L., Zhao, L., & Huang, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117140 · Cited by 44
Metadata
- Authors
- Matsuda, J., Takahashi, A., Takabatake, Y., Sakai, S., Minami, S., Yamamoto, T., Fujimura, R., Namba-Hamano, T., Yonishi, H., Nakamura, J., Kimura, T., Kaimori, J.-Y., Matsui, I., Takahashi, M., Nakao, M., Izumi, Y., Bamba, T., Matsusaka, T., Niimura, F., Yanagita, M., Yoshimori, T., & Isaka, Y.
- Affiliations
- The University of Osaka (JP)
- Department of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan
- National Institute of Biomedical Innovation, Health and Nutrition (JP)
- Kyushu University (JP)
- Tokai University (JP)
- Kyoto University (JP)
- Corresponding author
- Takabatake, Yoshitsugu
- ORCID
- Venue
- Autophagy
- Publisher
- Informa UK Limited
- Published
- 2020-01-16
- Volume
- 16
- Issue
- 10
- Pages
- 1889-1904
- ISSN
- 1554-8627 (ISSN-L)
- 1554-8635
- PMC
- PMC8386605
- OpenAlex
- W2999098705
- Cited by
- 44
- References
- 41
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 8 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 1
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Autophagy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- MSD Life Science Foundation, Public Interest Incorporated Foundation (none)
- Ono Medical Research Foundation (none)
- Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (15H06371, JP18K15975, JP18K08208, JP16K09614)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- Rubicon, autophagosome-lysosome fusion, metabolic syndrome, lipid metabolism, autophagic flux, triglyceride accumulation, oleic acid
- MeSH terms
- Lipidomics, Animals, Autophagy, Cell Membrane, Endocytosis, Epithelial Cells, Humans, Kidney Tubules, Proximal, Lysosomes, Male, Mice, Transgenic, Oxygen Consumption, Phospholipids, Mice, Knockout, Intracellular Signaling Peptides and Proteins, Lipid Metabolism, Mice, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells. https://app.cochat.ai/papers/10.1080/15548627.2020.1712107
- The paper
- Matsuda, J., Takahashi, A., Takabatake, Y., Sakai, S., Minami, S., Yamamoto, T., Fujimura, R., Namba-Hamano, T., Yonishi, H., Nakamura, J., Kimura, T., Kaimori, J.-Y., Matsui, I., Takahashi, M., Nakao, M., Izumi, Y., Bamba, T., Matsusaka, T., Niimura, F., . . . Isaka, Y. (2020). Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells. Autophagy. https://doi.org/10.1080/15548627.2020.1712107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.